[
  {
    "ts": "2026-01-16T02:09:51+00:00",
    "headline": "Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement",
    "summary": "Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver for point-of-care testing. See our latest analysis for Henry Schein. Investors have reacted positively to the CitoCBC agreement and recent M&A commentary, with the share price up 23.98% over the past 90 days and a 1-year total shareholder return of 8.82%. This suggests improving momentum after a...",
    "url": "https://finance.yahoo.com/news/henry-schein-hsic-valuation-check-020951767.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1c0b10a6-6e33-323f-873a-2d588bb7cc0c",
      "content": {
        "id": "1c0b10a6-6e33-323f-873a-2d588bb7cc0c",
        "contentType": "STORY",
        "title": "Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement",
        "description": "",
        "summary": "Henry Schein (HSIC) stock is in focus after the company secured exclusive U.S. distribution rights for CytoChip’s FDA-cleared CitoCBC system, the first cartridge-based CBC device with a CLIA Waiver for point-of-care testing. See our latest analysis for Henry Schein. Investors have reacted positively to the CitoCBC agreement and recent M&A commentary, with the share price up 23.98% over the past 90 days and a 1-year total shareholder return of 8.82%. This suggests improving momentum after a...",
        "pubDate": "2026-01-16T02:09:51Z",
        "displayTime": "2026-01-16T02:09:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/abf9bc7490ca3451384b081e1af2015f",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/q4rqfF5evrJ_pMBhQZsyvQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/abf9bc7490ca3451384b081e1af2015f.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3ewvWMjGc_oI2Ctn.eOtfA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/abf9bc7490ca3451384b081e1af2015f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-hsic-valuation-check-020951767.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/henry-schein-hsic-valuation-check-020951767.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]